Dr. Donadio is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
114 Woodland St
# Cancer
Hartford, CT 06105Phone+1 860-714-5554Fax+1 860-714-8047
Education & Training
- Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
- Tufts Medical CenterResidency, Internal Medicine, 1997 - 2000
- Uconn School Of MedicineClass of 1997
Certifications & Licensure
- CT State Medical License 2004 - 2025
- NY State Medical License 2000 - 2005
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 4 citationsMulticenter Phase 2 Trial of Gemcitabine, Carboplatin, and Sorafenib in Patients With Metastatic or Unresectable Transitional-Cell CarcinomaMichael E. Hurwitz, Paul Markowski, Xiaopan Yao, Hari Anant Deshpande, Jaymin M. Patel
Clinical Genitourinary Cancer. 2018-12-01 - 280 citationsCombination of Paclitaxel, Ifosfamide, and Cisplatin Is an Effective Second-Line Therapy for Patients With Relapsed Testicular Germ Cell TumorsG. Varuni Kondagunta, Jennifer Bacik, Alessia Donadio, Dean F. Bajorin, Stephanie Marion
Journal of Clinical Oncology. 2005-09-20 - 148 citationsChemotherapy for Teratoma With Malignant TransformationAlessia Donadio, Robert J. Motzer, Dean F. Bajorin, Philip W. Kantoff, Joel Sheinfeld
Journal of Clinical Oncology. 2003-12-01
Press Mentions
- Management of Testicular Germ Cell Tumor with Somatic-Type MalignancyJune 10th, 2022
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: